Prostate Cancer
Upper limit of cancer extent on biopsy defining very low risk prostate cancer - Abstract
September 2, 2014
Usefulness of ultra-sensitive prostate-specific antigen following radical prostatectomy - Abstract
September 2, 2014
Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone - Abstract
September 2, 2014
Ipilimumab: A potential immunologic agent in the treatment of metastatic castration-resistant prostate cancer - Abstract
August 29, 2014
Argument for prostate cancer screening in populations of African-Caribbean origin - Abstract
August 29, 2014
Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study - Abstract
August 29, 2014
USANZ: The 'Timing of androgen deprivation therapy in incurable prostate cancer' protocol (TOAD) - where are we now? - Abstract
August 29, 2014
Incidence of second malignancies for prostate cancer - Abstract
August 29, 2014
Improving PET spatial resolution and detectability for prostate cancer imaging - Abstract
August 29, 2014
The diagnostic accuracy of MRI PI-RADS scoring in a transperineal prostate biopsy setting - Abstract
August 29, 2014
Androgen deprivation therapy for prostate cancer: Long-term safety and patient outcomes - Abstract
August 29, 2014